Associate Clinical Professor of Pediatrics, Morehouse School of Medicine
Pediatric Hematology & Oncology
Dr. Beatrice E. Gee, MD
|
|
Give Review
Dr. Beatrice E. Gee is an expert in the field of Pediatric Hematology & Oncology. She studied medicine at Tufts University School of Medicine. Tufts University School of Medicine has a rank of 49 in research and a 52 in primary care She received awards:"Atlanta Magazine: Top Doctors" and "Atlanta Top Doctor - Pediatric Hematology/Oncology". Beatrice E. Gee, MD is a published doctor as well. She has 13 publications published. The latest was: Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.
Publications
- Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell Anemia and high stroke risk.
- Elevated circulating angiogenic progenitors and white blood cells are associated with hypoxia-inducible angiogenic growth factors in children with Sickle cell disease.
- Early Alterations of the Immune Transcriptome in Cultured Progenitor Cells From Obese African-American Women.
- Plasma interleukin-1beta concentration is associated with stroke in Sickle cell disease.
- Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell Anemia.
- Proinflammatory cytokines and the hypermetabolism of children with Sickle cell disease.
- Effect of hydroxyurea on growth in children with sickle cell Anemia: results of the HUG-KIDS Study.
- Biologic complexity in Sickle cell disease: implications for developing targeted therapeutics.
- Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with Sickle cell disease.
- Predictors of fetal hemoglobin response in children with sickle cell Anemia receiving hydroxyurea therapy.
- Safety of hydroxyurea in children with sickle cell Anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.
- Serum ferritin level changes in children with Sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.
Schools
Tufts University School Of Medicine
Chldns HospHarvard University
Conditions Treated
- Anemia
- Neutropenia
- Sickle Cell Disease
- Thalassemia
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Atlanta Magazine: Top Doctors
- Atlanta Top Doctor - Pediatric Hematology/Oncology
Education
-
Boston Children's Hospital -
Tufts University School of Medicine
Hospital
-
Grady Memorial Hospital -
Children's Healthcare of Atlanta
Helpful Reviews
Similar Doctors
|
|
Dr. William T. Cash, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeanne M. Boudreaux, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leslie S. Kean, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Olufolake A. Adisa, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Lakshmanan Krishnamurti, MB
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|